CRM Publications

Gangoso E, Thirant C, Chneiweiss H, Medina JM, Tabernero A.  2014.  A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.Cell Death Dis. 5:e1023.

Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK et al..  2013.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.Cancer Discov. 3(2):198-211.

Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 27(9):1032-45.

Carén H, Pollard SM, Beck S.  2013.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Mol Aspects Med. 34(4):849-62.

Natalwala A, Bharkhada V, Noel G, Cruickshank G.  2011.  Comparison of time taken from initial presentation to histological diagnosis of Glioblastoma Multiforme (GBM) in Birmingham, United Kingdom and Strasbourg, France.Clin Neurol Neurosurg. 113(5):358-61.

Shimizu K, Kondo T, Iwata Y, Mukawa J, Mogami H, Nishikubo Y, Miura T, Mitomo M.  1979.  [Lipoma of the Corpus Callosum--one surgically operated case (author's transl)].No Shinkei Geka. 7(12):1179-83.